Please use this identifier to cite or link to this item:
Title: Tumor cell dormancy
Author: Gomis i Cabré, Roger
Gawrzak, Sylwia
Keywords: Cèl·lules canceroses
Cancer cells
Issue Date: 7-Oct-2016
Publisher: Wiley
Abstract: Metastasis is the primary cause of death in cancer patients and current treatments fail to provide durable responses. Efforts to treat metastatic disease are hindered by the fact that metastatic cells often remain dormant for prolonged intervals of years, or even decades. Tumor dormancy reflects the capability of disseminated tumor cells (DTCs), or micrometastases, to evade treatment and remain at low numbers after primary tumor resection. Unfortunately, dormant cells will eventually produce overt metastasis. Innovations are needed to understand metastatic dormancy and improve cancer detection and treatment. Currently, few models exist that faithfully recapitulate metastatic dormancy and metastasis to clinically relevant tissues, such as the bone. Herein, we discuss recent advances describing genetic cell-autonomous and systemic or local changes in the microenvironment that have been shown to endow DTCs with properties to survive and eventually colonize distant organs.
Note: Reproducció del document publicat a:
It is part of: Molecular Oncology, 2016, vol 11, num. 1, p. 62-78
Related resource:
ISSN: 1878-0261
Appears in Collections:Articles publicats en revistes (Institut de Recerca Biomèdica (IRB Barcelona))

Files in This Item:
File Description SizeFormat 
2950.pdf1.95 MBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons